TE_165
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2b_3end, L2 |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | MFAP2 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 3.38 |
| Counts of samples | TCGA_tumor:380; TCGA_normal:6; GTEx:120 |
| TSS | chr1(-):16977480 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_165.1 | MFAP2 | Chimeric | Non-coding | Non-coding | chr1(-):16975003,16975023,16975269,16975342,16975643,16975730,16976501,16976545,16976708,16976794,16976897,16976923,16977109,16977198,16977403,16977481 |
| teRNA_165.2 | MFAP2 | Chimeric | Non-coding | Non-coding | chr1(-):16975710,16975730,16976501,16976545,16976708,16976923,16977109,16977198,16977403,16977481 |
| teRNA_165.3 | MFAP2 | Chimeric | Non-coding | Non-coding | chr1(-):16976525,16976545,16976708,16976794,16976897,16976923,16977109,16977198,16977403,16977481 |
| teRNA_165.4 | MFAP2 | Chimeric | Non-coding | Non-coding | chr1(-):16976525,16976545,16976708,16976923,16977109,16977198,16977403,16977481 |
| teRNA_165.5 | MFAP2 | Chimeric | Non-coding | Non-coding | chr1(-):16975003,16975023,16975269,16975342,16975643,16975730,16976501,16976545,16976708,16976794,16976897,16976923,16977109,16977195,16977403,16977481 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
